CASI Pharmaceuticals & BioInvent
1,724
20
2023-5-12 15:28
CASI Pharmaceuticals – executive interview – from EDISON
骶髂关节后路螺丝钉内固定
Rare case of hemorragic transformation of type 2/5 isthmic myoma
骨关节炎
Wellens T waves & de Winter T waves
腰椎椎间关节经椎板螺丝钉固定
Total laparoscopic hysterectomy
Acute management of pelvic ring injuries - 1 of 2
0 bullet chats
Please Sign In first
120101
Scan by WeChatUnauthorized reproduction is prohibited
BioStock interviews BioInvent's CEO Martin Welschof and Wei-Wu He, Chairman & CEO of CASI Pharmaceuticals about their collaboration on BioInvent's propriety asset, the drug candidate and antibody BI-1206.
Comments 0
Please to post a comment~
Loading...
Related Suggestion